Explore our company news and media resources.

Contact us

Global Communications 
1000 Mylan Blvd. Canonsburg, PA 15317

+1. 724.514.1968

More info

Aug 30, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021. Chief Financial Officer...

Aug 30, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at Citi's 16th Annual BioPharma Conference on Friday, September 10, 2021. Chief Executive Officer...

Aug 9, 2021

Reports Second Quarter 2021 Financial Results - Total Revenues of $4.58 billion, U.S. GAAP Net Loss of $279 million, Adjusted EBITDA of $1.68 billion, U.S. GAAP Net Cash Provided by Operating...

Jul 28, 2021

Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) today announced that the U.S. Food and Drug Administration (FDA) has approved Semglee® (insulin glargine-yfgn) injection....

Jul 27, 2021

Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer by KPH Healthcare...

Browse press releases

Featured Stories

Saving the Planet, One Ugly Fruit at a Time

A team of Viatris employees in Portugal volunteered to sort through misshapen produce to help reduce food waste.  

Learn more

Featured News
Sep 15, 2021

Rachel Battaglia Hileman started working with the Legal team shortly after earning her paralegal certificate. Her goals were clear. The path? Not so much.

Sep 20, 2021

We created this new company with a deep commitment to diversity and inclusion. And I’m pleased to report we’re taking important steps to progress this work.

Sep 13, 2021

Antimicrobial resistance (AMR) is a prominent public health threat that is already impacting hundreds of thousands of patients each year.

Browse articles

In the News
Nov 17, 2020
VIATRIS™ started trading today on Nasdaq, and Executive Chairman Robert J. Coury and CEO Michael Goettler shared their excitement during an interview at Nasdaq’s global Client Experience Center, located in the heart of Times Square in New York City.
Stay Connected